MetLife Investment Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

MetLife Investment Management’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,347	Closed	-$623K	–	2842
2023 Q4	$623K	Hold	59,347	–	–	﹤0.01%	1564
2023 Q3	$780K	Hold	59,347	–	–	0.01%	1368
2023 Q2	$748K	Hold	59,347	–	–	0.01%	1435
2023 Q1	$774K	Hold	59,347	–	–	0.01%	1372
2022 Q4	$1.05M	Hold	59,347	–	–	0.01%	1197
2022 Q3	$904K	Hold	59,347	–	–	0.01%	1244
2022 Q2	$880K	Sell	59,347 -8,947	-13%	-$167K	0.01%	1276
2022 Q1	$1.54M	Buy	68,294 +24,794	+57%	+$502K	0.01%	1106
2021 Q4	$803K	Hold	43,500	–	–	0.01%	1226
2021 Q3	$582K	Sell	43,500 -7,040	-14%	-$114K	0.01%	1445
2021 Q2	$935K	Sell	50,540 -9,698	-16%	-$163K	0.01%	1205
2021 Q1	$904K	Sell	60,238 -7,674	-11%	-$123K	0.01%	1205
2020 Q4	$981K	Sell	67,912 -9,659	-12%	-$117K	0.01%	1146
2020 Q3	$631K	Hold	77,571	–	–	0.01%	1246
2020 Q2	$525K	Sell	77,571 -93,200	-55%	-$604K	0.01%	1353
2020 Q1	$1.2M	Hold	170,771	–	–	0.02%	823
2019 Q4	$1.68M	Sell	170,771 -3,730	-2%	-$39.3K	0.02%	875
2019 Q3	$1.92M	Sell	174,501 -1,678	-1%	-$17.2K	0.02%	807
2019 Q2	$2.05M	Sell	176,179 -5,598	-3%	-$56.9K	0.02%	806
2019 Q1	$1.73M	Sell	181,777 -2,090	-1%	-$23.1K	0.02%	876
2018 Q4	$1.77M	Sell	183,867 -366	-0.2%	-$4.08K	0.02%	798
2018 Q3	$2.63M	Sell	184,233 -12,933	-7%	-$176K	0.03%	742
2018 Q2	$2.37M	Sell	197,166 -1,018	-0.5%	-$12.5K	0.03%	735
2018 Q1	$2.45M	Sell	198,184 -1,458	-0.7%	-$20.7K	0.03%	704
2017 Q4	$2.9M	Buy	+199,642	New	+$2.77M	0.03%	651

Other funds holding MDRX

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MetLife Investment Management's MDRX Position: Q1 2024 in Review

MetLife Investment Management sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 59,347 shares — an estimated $623K sold.

MetLife Investment Management first reported a position in MDRX in Q4 2017 and held it in 25 quarters. The position peaked at $2.9M in Q4 2017. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

MetLife Investment Management reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
MetLife Investment Management sold 59,347 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $623K.
MetLife Investment Management first reported a position in Veradigm Inc. Common Stock in Q4 2017 and held it in 25 quarters.
MetLife Investment Management's Veradigm Inc. Common Stock position peaked at $2.9M in Q4 2017.
35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.